Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio ...
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a ...
Atria Investments Inc lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 19.5% during the fourth ...
5d
Zacks Investment Research on MSNHere's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
The headbands were out on Wednesday in Memphis. All but one member of the Utah Jazz sported white NBA headbands for its game ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
Markkanen (back) is questionable for Wednesday's game against Memphis.
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Today, the TSC Alliance® announced its 24th Annual Comedy for a Cure® will be held Sunday, April 6, once again at the ...
Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results